Tao Capital Management’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$39.4M Hold
828,815
33.14% 1
2025
Q4
$26.3M Hold
828,815
22.63% 2
2025
Q3
$23.3M Hold
828,815
17.64% 3
2025
Q2
$30.5M Hold
828,815
22.36% 2
2025
Q1
$32.5M Hold
828,815
28.02% 2
2024
Q4
$38.5M Hold
828,815
26.88% 2
2024
Q3
$37.4M Hold
828,815
33.91% 1
2024
Q2
$40.8M Hold
828,815
33.48% 1
2024
Q1
$28.4M Hold
828,815
26.94% 2
2023
Q4
$30.6M Hold
828,815
27.95% 1
2023
Q3
$16.8M Hold
828,815
13% 3
2023
Q2
$17M Hold
828,815
12.42% 4
2023
Q1
$12.5M Hold
828,815
9.94% 4
2022
Q4
$19.7M Hold
828,815
14.84% 3
2022
Q3
$29.2M Hold
828,815
19.15% 2
2022
Q2
$29M Hold
828,815
20.06% 1
2022
Q1
$40.9M Hold
828,815
14.93% 3
2021
Q4
$64.1M Hold
828,815
19.6% 1
2021
Q3
$88.7M Hold
828,815
23.62% 1
2021
Q2
$110M Hold
828,815
25.34% 2
2021
Q1
$103M Sell
828,815
-275,399
-25% -$41.8M 29.65% 1
2020
Q4
$156M Sell
1,104,214
-127,744
-10% -$14.2M 38.37% 1
2020
Q3
$93.6M Sell
1,231,958
-88,000
-7% -$5.48M 30.17% 2
2020
Q2
$59.8M Sell
1,319,958
-135,122
-9% -$4.85M 23.63% 3
2020
Q1
$44.5M Sell
1,455,080
-210,758
-13% -$5.67M 20.89% 3
2019
Q4
$35M Buy
+1,665,838
New +$39M 17.24% 3

Other funds holding TWST

Tao Capital Management's TWST Position: Q1 2026 in Review

Tao Capital Management held its Twist Bioscience (TWST) position steady in Q1 2026 at 828,815 shares worth $39.4M. The position accounts for 33.14% of the portfolio, ranked #1.

Tao Capital Management first reported a position in TWST in Q4 2019 and has held it in 26 quarters since. The position peaked at $156M in Q4 2020. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Tao Capital Management held 828,815 shares of Twist Bioscience worth $39.4M as of Q1 2026.
  • Tao Capital Management left its Twist Bioscience share count unchanged in Q1 2026.
  • Twist Bioscience made up 33.14% of Tao Capital Management's portfolio in Q1 2026, its #1 holding.
  • Tao Capital Management first reported a position in Twist Bioscience in Q4 2019 and has held it in 26 quarters since.
  • Tao Capital Management's Twist Bioscience position peaked at $156M in Q4 2020.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Tao Capital Management's 13F filing for Q1 2026, filed 14 May 2026.